Sign In
Last checked at 
30 Sep 2021 08:45
30 September 2021
Dr. Martens plc (the "Company")
Block Listing application
The Company announces today that application has been made to the FCA and to the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's main market for a block listing of securities in respect of a total of 200,000 ordinary shares of GBP 0.01 each (the "Ordinary Shares") in the Company. It is expected that admission will become effective on 4 October 2021.
The Ordinary Shares are being reserved under a block listing and will be issued under the Company's share plans.
The Company anticipates it will first use the Ordinary Shares reserved under the block listing in connection with an all-employee award of free shares in order to reward our teams and further align our people with the long-term success of the business.
When issued the Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.
Enquiries:
Bethany Barnes, Director of Investor Relations
bethany.barnes@drmartens.com
Paul Rolling, Assistant Company Secretary
paul.rolling@drmartens.com
About Dr. Martens plc
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.
Follow the stocks
